Maggie joined the Partnership Development Office at the Frederick National Laboratory for Cancer Research (FNLCR) in 2018. In her new role, she supports the mission of FNLCR by advocating partnerships among our scientist and external researchers in government, academic, industry and nonprofit research community. As a shared resource, FNLCR and its partners accelerate progress against cancer and AIDS by bridging the gap between late discovery and early development of diagnostics and therapeutics. Before this role, Maggie was a scientist at the Nanotechnology Characterization Lab at FNLCR, supporting communications and partnerships between NCL and its collaborators. She spent over 9 years at the laboratory bench engineering and validating nanoparticles for drug delivery and imaging applications, predominantly for cancer indications. Maggie was a postdoctoral fellow at Johns Hopkins Institute for NanoBioTechnology and Johns Hopkins School of Medicine’s Department of Radiology. In addition, she spent time as a program manager at a Maryland start-up company dedicated to the clinical translation of biopharmaceuticals for cancer, diabetes and rare disease indications. As a doctoral student, Maggie was in the NIH Intramural Research Program at the National Institute of Biomedical Imaging and Bioengineering. She received her Ph.D. in Biomedical Engineering from Stony Brook University in 2012 and her B.S. in Bioengineering from Lehigh University in 2007.